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Determining the cellular source of new skeletal
elements is critical for understanding appendage re-
generation in amphibians and fish. Recent lineage-
tracing studies indicated that zebrafish fin ray bone
regenerates through the dedifferentiation and prolif-
eration of spared osteoblasts, with limited if any con-
tribution from other cell types. Here, we examined
the requirement for this mechanism by using genetic
ablation techniques to destroy virtually all skeletal
osteoblasts in adult zebrafish fins. Animals survived
this injury and restored the osteoblast population
within 2 weeks. Moreover, amputated fins depleted
of osteoblasts regenerated new fin ray structures at
rates indistinguishable from fins possessing a resi-
dent osteoblast population. Inducible genetic fate
mapping confirmed that new bone cells do not arise
from dedifferentiated osteoblasts under these con-
ditions. Our findings demonstrate diversity in the
cellular origins of appendage bone and reveal that
de novo osteoblasts can fully support the regenera-
tion of amputated zebrafish fins.
INTRODUCTION
After amputation of an appendage in certain salamanders and
fish, new cartilage or bone structures of correct size and pattern
emerge from a mound of proliferative tissue called the blastema
(Brockes and Kumar, 2005). A major objective in the field has
been to define the cellular source(s) of regenerated skeletal
elements. This includes identifying cell types within the ap-
pendage stump that normally give rise to regenerated cartilage
or bone after amputation, as well as identifying cells that have
the developmental capacity to create skeleton under additional
conditions (Poss, 2010; Tanaka and Reddien, 2011). Proposed
sources are the differentiated chondrocytes and osteoblasts
themselves, or nonskeletal cells that undergo new differentiation
or transdifferentiation events after amputation.
Grafting experiments in amphibians performed over the past
century have attempted to resolve this issue. Surgical transplan-
tation of dissected cartilage or bone indicated that skeletal
tissues wholly or predominantly contribute like tissue, suggest-
ing that lineage is restricted throughout blastema formation
and patterning (Namenwirth, 1974; Steen, 1968, 1970). Yet,Deveother experiments, including the transplantation of dye-labeled
muscle cells to limb blastemas or nonskeletal tissue to irradiated
limbs, indicated that additional cell types may act as progenitors
for bone or cartilage (Lo et al., 1993; Morrison et al., 2006). A
recent study of axolotl limb regeneration examined the contribu-
tions of tissues grafted from transgenic animals constitutively
expressing a fluorescent reporter protein. These experiments
generated the prevailingmodel for axolotl limb cartilage regener-
ation, which is that cartilage cells predominantly contribute like
tissue, while one or more cell populations within the dermis
also has the potential to form cartilage (Kragl et al., 2009).
Tissue grafts can be ineffective at resolving certain key ques-
tions of tissue origin, such as (1) how host tissue naturally partic-
ipates in regeneration; (2) the extent to which specific cell types
contribute during regeneration; and (3) whether cells in the
stump undergo developmental changes like dedifferentiation in
the process of creating new structures. Very recently, three
studies examined similar questions during fin regeneration in
zebrafish by genetic lineage tracing of specific cell types. Adult
zebrafish fins contain several cylinder-shaped, segmented
bony fin rays that are lined by osteoblasts and encase fibro-
blasts, blood vessels, nerves, and pigment cells. By inducible
fate mapping of cells expressing the intermediate osteoblast
marker osterix, Knopf and colleagues found that existing osteo-
blasts undergo partial dedifferentiation, as defined by reduced
expression of osteoblast markers, after which they proliferate
and contribute solely to regenerated bone structures (Knopf
et al., 2011). Tu and Johnson assessed the mosaicism of trans-
genes injected into embryos during rapid cell division and found
that transgenic clones containing labeled osteoblasts within
regenerated fins do not possess other cell types (Tu and John-
son, 2011). Sousa and colleagues used live imaging of labeled
osteocalcin-expressing cells to indicate contribution of differen-
tiatedosteoblasts to the regenerate (Sousaetal., 2011). Together,
these studies supported a common conception that osteoblasts
in the regenerate derive predominantly or wholly from the dedif-
ferentiation, proliferation, and migration of lineage-restricted
stump osteoblasts.
Here, by creating a system to facilitate inducible ablation of
resident osteoblasts in adult fins, we examined the extent to
which zebrafish fin regeneration is dependent on these cells.
We found by lineage tracing of existing osteoblasts that they
are restricted to contributing like cells during regeneration, in
agreement with recent published work. Unexpectedly, however,
ablation of ostensibly all osteoblasts prior to amputation did not
slow down the rate of zebrafish fin regeneration. Instead, new
osteoblasts arose from cells that differentiated de novo after
amputation, a result confirmed by genetic fate mapping. Ourlopmental Cell 22, 879–886, April 17, 2012 ª2012 Elsevier Inc. 879
Figure 1. Resident Osteoblasts Contribute New Osteoblasts to
Regenerating Fin Structures
(A) Cartoon summarizing strategy for inducible, genetic fate mapping of
osteoblasts during zebrafish fin regeneration. 4-HT treatment labels osterix-
expressing cells with EGFP prior to amputation.
(B and C) Uninjured osx:CreER; b-act2:RSG fins, shown as whole mount (B)
and in a longitudinal section (C), display no labeling after vehicle treatment.
Zns5 (magenta) is an uncharacterized antigen that helps identify osteoblasts
lining hemiray bone (Johnson and Weston, 1995). This antibody stains cell
membranes and visualizes as noncontiguous staining in sections. (C) The
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880 Developmental Cell 22, 879–886, April 17, 2012 ª2012 Elsevier Ifindings indicate that stump osteoblasts are a dispensable
source for regenerating appendage bone and provide important
new context for understanding mechanisms of robust skeletal
regeneration.
RESULTS
Lineage-Restricted Contributions byOsteoblasts during
Zebrafish Fin Regeneration
To identify contributions by osteoblasts after zebrafish fin ampu-
tation, we used an inducible genetic fate-mapping approach.
We screened several candidate genes for bone-specific expres-
sion as a prerequisite for genetic fate mapping. osterix (also
known as sp7) is a zinc finger transcription factor whose expres-
sion is first seen during intermediate stages of osteoblast
differentiation (Li et al., 2009; Renn andWinkler, 2009). osteocal-
cin (also known as bglap), expressed by mature osteoblasts,
has been used as a marker of terminal osteogenesis (Inohaya
et al., 2007). We generated transgenic reporter lines to visu-
alize the activity of the teleost osterix and osteocalcin re-
gulatory sequences. Tg(osterix:mCherry)pd43 (osx:mCherry) and
Tg(osteocalcin:EGFP)pd44 (osc:EGFP) each showed osteoblast-
specific fluorescence in uninjured adult zebrafish fins that was
excluded from medially located fibroblasts and from epidermis.
osx:mCherry visualized a larger pool of osteoblasts than
osc:EGFP (Figures S1A–S1D available online). Regenerated
osteoblasts labeled by osterix-driven mCherry expression could
be detected as early as 2 days postamputation (dpa), whereas
osteocalcin-driven enhanced green fluorescent protein (EGFP)
expression was not detectable until 7 dpa (Figures S1E–S1H).
To fate-map differentiated osteoblasts, we generated a trans-
genic line with osterix regulatory sequences driving a tamoxifen-
inducible Cre recombinase-Estrogen receptor fusion protein
Tg(osterix:mTagBFP-2A-CreER)pd45 (osx:CreER) (Figure S1I).
An indicator line, Tg(bactin2-Lox-DsRed-STOP-Lox-EGFP)s928
(b-act2:RSG) permitted visualization of EGFP fluorescence after
Cre-mediated excision of loxP-flanked stop sequences, and
was expressed in adult osteoblasts, intraray fibroblasts, and
epidermis (Figure S1J) (Kikuchi et al., 2010). To label osteo-
blasts, we incubated osx:CreER; b-act2:RSG animals with
4-hydroxytamoxifen (4-HT) or vehicle for 1 day (Figure 1A).
Within 2 days, EGFP+ cells were visible lining the osteoblast
compartment in fin rays of animals treated with 4-HT (Figures
1B–1E). We did not observe EGFP+ cells in intraray fibroblasts,
located medially to osteoblasts in longitudinal fin sections.
These data indicate that osx:CreER inducibly and specifically
labels osteoblasts.longitudinal fin section is labeled to show structures: intraray fibroblasts (if),
osteoblasts (ob), and epidermis (e).
(D and E) 4-HT treatment labels many osteoblasts with EGFP in uninjured fins,
shown as a whole-mount image (D) and a longitudinal section (E).
(F–M) EGFP+ osteoblasts labeled by 4-HT treatment prior to fin amputation
contribute labeled progeny to the regenerate, visualized by whole-mount
images and in sections at 2 (F and G), 3 (H and I), 4 (J and K), and 7 (L and M)
dpa. EGFP fluorescence proximal and distal to the amputation plane is
restricted to the osteoblast compartment and is not present in intraray
fibroblasts or epidermis. Arrowheads indicate the plane of amputation. Scale
bars = 100 mm.
See Figure S1.
nc.
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regenerate, we amputated the caudal fins of zebrafish 2 days
after 4-HT treatment (Figure 1A). EGFP+ cells were detected in
regenerating fins from 2 dpa onward, a result that indicated
contribution from osteoblasts within the stump. As regeneration
progressed to 3, 4, and 7 dpa, the domain of EGFP+ expression
expanded distally within the regenerate. Confocal analysis of fin
sections at 2, 3, 4, and 7 dpa revealed EGFP+ cells confined to
regions lining bone matrix both below and above the amputation
plane, indicating that a population of osteoblasts in the regen-
erate is derived from stump osteoblasts. No EGFP+ expression
was observed in intraray fibroblasts or other cell types (Figures
1F–1M). Thus, in agreement with similar experiments published
recently (Knopf et al., 2011), our data support a mechanism in
which contributions of osterix-expressing cells are restricted to
the osteoblast lineage during zebrafish fin regeneration.
Genetic Ablation and Recovery of Zebrafish Osteoblasts
Although these data indicated that spared osteoblasts
contribute new bone during regeneration, we and others (Knopf
et al., 2011; Sousa et al., 2011) could not assess the relative level
of contribution versus other potential sources due to incomplete
labeling efficiency. In addition and perhaps more importantly,
these findings did not address the extent to which fin regenera-
tion is dependent on cellular contributions by resident osteo-
blasts. To probe the regenerative capacity of zebrafish fins after
massive osteoblast loss, we generated a transgenic line contain-
ing a mCherry-tagged, human codon-optimized version of the
Escherichia coli enzyme Nitroreductase (NTR) downstream of
osterix regulatory sequences, Tg(osterix:mCherry-NTRo)pd46
(osx:NTR) (Grohmann et al., 2009). NTR reduces exogenously
added metronidazole (Mtz) prodrug to form a cytotoxic product
with negligible bystander effects, and has been employed
successfully to ablate specific cell types in zebrafish larvae
(Curado et al., 2007; Pisharath et al., 2007). Treatment of
osx:NTR; osc:EGFP fish for 24 hr with 10 mM Mtz caused
a dramatic loss of osx- and osc-driven fluorescence throughout
the fish by 4 days posttreatment (dpt) (Figure 2A). We did not
observe impaired movement or behavior in these animals.
TUNEL staining of caudal fins indicated extensive induction of
apoptosis in osteoblasts lining the fin bone of osx:NTR fish that
had been treated 1 day prior with Mtz (Figure 2B; Figure S2A).
While we could not detect osx- or osc-driven fluorescence in
Mtz-treated fin tissue, we cannot exclude the possibility that
a small number of fin osteoblasts were spared. To confirm deple-
tion of fin osteoblasts, we performed flow cytometry on caudal
fin tissues of osx:NTR; osc:EGFP fish that had been treated
with vehicle or Mtz (Figures 2C and 2D). Mtz treatment deci-
mated the osc:EGFP+ cell population, yielding fins with no signif-
icant difference in osc:EGFP+ events from nontransgenic
animals (Figure 2D). Thus, we created a system that permitted
massive depletion of virtually all adult zebrafish fin osteoblasts.
To determine the longer term consequences of this procedure,
we followed osx-driven mCherry-NTR fusion protein and
osc:EGFP fluorescence after Mtz treatment. osx:NTR; osc:EGFP
caudal fins began to recover osteoblast marker expression by 7
dpt, with virtually complete restoration by 2 weeks (Figures
2E–2L). Similar loss of marker expression was observed in
cranial structures and hypurals at 4 dpt, with significant recoveryDeveby 7 and 14 dpt (Figures S2B and S2C). Fin osteoblast loss and
recovery was accompanied by cell proliferation, indicative of an
injury response. We detected increased nuclear Bromodeoxyur-
idine (BrdU) incorporation, a marker of DNA synthesis, mainly in
epidermal cells at 4 dpt (Figure 2M; Figure S2D). We also
observed BrdU-positive cells between hemirays; these cells
did not express detectable osterix:NTR fluorescence or peri-
ostin, prrx1a, or prrx1b, orthologs of genes that markmammalian
periosteal cells (data not shown). Our results indicate that zebra-
fish regenerate their fin osteoblast compartment within 2 weeks
of its genetic depletion.
Osteoblast-Depleted Fins Regenerate Normally after
Amputation
To examine whether regeneration of amputated fins can initiate
and progress without a notable source of bone, we treated
osx:NTR fish with Mtz or vehicle for 24 hr, returned animals to
aquarium water for 2 days, visually confirmed loss of transgene
fluorescence, and amputated fins (Figure 3A). We then imaged
and measured fin regenerates every 2 days after amputation
over a course of 14 days. As negative controls, we measured
the rate of fin regeneration of wild-type fish treated with Mtz
2 days prior to amputation. Unexpectedly, we observed no
significant difference in the rates of regeneration among these
three groups at any time points (Figure 3B). By contrast, a post-
amputation Mtz treatment (4 dpa) slowed regenerative events
significantly, indicating that depletion of osteoblasts partici-
pating in regeneration impedes the process (Figures S3A–
S3C). The lengths of regenerated fins at 30 dpa were similar after
each of these treatments (Figure S3D). Importantly, our data
indicate that, although osteoblasts in the appendage stump
make contributions to regenerated bone, they are dispensable
for regeneration of bony fin rays.
To identify developmental responses during fin regeneration
that are only observed after osteoblast depletion, we analyzed
marker expression in osx:NTR; osc:EGFP animals at various
time points postamputation. Fins from animals treated with
Mtz prior to amputation lacked detectable osx:NTR fluorescence
proximal to the amputation plane at 2–4 dpa, except for a small
trail of osx-expressing cells at the injury site in 3 and 4 dpa fins. In
situ hybridization for endogenous osx and runx2a, a transcription
factor that marks early osteoblasts (Li et al., 2009), gave similar
results. However, they displayed prominent osx:NTR fluores-
cence and endogenous osx and runx2a expression distal to
the amputation plane, indicating that the differentiation kinetics
of osteoblasts in regenerating structures were distinct from
those in existing fin tissue (Figures 3C–3E, 3G, 3I, 3K, 3M, and
3O; Figures S3E and S3F). Analysis of sections revealed that
recovered osx:NTR fluorescence was restricted to the typical
osteoblast compartment in the regenerate at 2 dpa (Figures 3F
and 3H). However, by 4 dpa, and occasionally detectable at 3
dpa, osx:NTR fluorescence was present in a portion of medially
located intraray fibroblasts near the amputation plane in Mtz-
treated animals (Figures 3J, 3L, 3N, and 3P). We occasionally
detected osx mRNA in a similar region of intraray fibroblasts at
3 dpa in Mtz-treated animals (Figure S3F). By 7–8 dpa, this
ectopic expression was no longer detectable (data not shown),
and osx:NTR; osc:EGFP fluorescence began to recover through-
out the proximodistal axis of the fins (Figure S3B). Theselopmental Cell 22, 879–886, April 17, 2012 ª2012 Elsevier Inc. 881
Figure 2. Inducible Ablation and Recovery
of Adult Zebrafish Osteoblasts
(A) Juvenile osx:NTR; osc:EGFP fish treated with
vehicle (left) or Mtz (right) and assessed for fluo-
rescence 4 days later. There was no detectable
marker expression in Mtz-treated animals. Scale
bar = 1 mm.
(B) TUNEL staining of osx:NTR fins 24 hr after
vehicle (left) or Mtz (right) treatment, indicating
profound, osteoblast-specific apoptosis (white) in
Mtz-treated fish. Higher magnification images are
shown in Figure S2. Scale bar = 100 mm.
(C) Flow cytometric analysis of caudal fin cells
from wild-type (nontransgenic) and osx:NTR;
osc:EGFP fish treated with vehicle or Mtz. Single
cell suspensions were stained with propidium
iodide (PI) and analyzed for EGFP. Representative
plots are shown in (C); numbers in the lower right
box indicate relative percentages of osc:EGFP+
cells.
(D) Absolute osc:EGFP cell counts (per 10,000
cells) from data in (C). Data are mean ± SEM from
nine animals each. ***p < 0.001, Student’s t test.
Wild-type and Mtz-treated osx:NTR; osc:EGFP
samples show no significant difference in
osc:EGFP+ cells, indicative of complete osteo-
blast loss.
(E–H) Caudal fins of osx:NTR; osc:EGFP fish lose
osteoblast fluorescence within 4 days of Mtz
treatment (E and F). Expression of osx:NTR can be
detected beginning at 7 days posttreatment (dpt)
(G), more easily in tissue sections than whole-
mount images. Expression recovers completely
by 14 dpt (H). Scale bar = 1 mm.
(I–L) Longitudinal sections of osx:NTR fins at time
points indicated in (E)–(H). osx:NTR fluorescence
disappears by 4 dpt and recovers in the osteoblast
compartment by 14 dpt. Scale bar = 100 mm.
(M) BrdU immunofluorescence (green) analysis of
vehicle- (left) or Mtz-treated (right) osx:NTR ani-
mals 4 days posttreatment, indicating enhanced
cellular DNA synthesis in Mtz-treated samples.
Scale bar = 100 mm.
See Figure S2.
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Bone Source Diversity in Regenerating Finsobservations of (1) normal regeneration after massive osteoblast
ablation; (2) temporally isolated activation of the osteoblast regu-
latory program in regenerating tissue versus uninjured areas; and
(3) osterix-driven expression in medial fibroblast areas were
consistent with existence of an alternative regenerative source
to stump osteoblasts.
Osteoblasts Arise De Novo in Fin Regenerates after
Ablation of the Resident Population
While these findings implicated a nonosteoblast source, it re-
mained formally possible that a portion of existing osteoblasts
mimicked ablation by downregulating osteoblast markers
upon Mtz treatment, and then recovered to contribute a new
pool of osteoblasts to the regenerate. To address this mecha-
nism, we first bathed uninjured osx:CreER; b-act2:RSG;
osx:NTR animals in 4-HT for 24 hr to tag osteoblasts with an irre-882 Developmental Cell 22, 879–886, April 17, 2012 ª2012 Elsevier Iversible b-actin2-driven label (Figures 4A and 4B). Two days
after genetic labeling, we treated these fish with Mtz for 24 hr,
depleting all detectable EGFP fluorescence within 2 days
(Figures 4C and 4H). We then amputated these fins and exam-
ined them at 4 dpa for reemergence of b-actin2-driven EGFP
fluorescence in the regenerate. No EGFP fluorescence was
detectable after this protocol (Figure 4D). To confirm these
results, we assessed fin samples by cell dissociation and flow
cytometry for b-actin2-driven EGFP. While uninjured fins from
4-HT-treated animals had many EGFP+ events, Mtz treatment
depleted these events to background (EtOH-treated) levels (Fig-
ure S4A). EGFP+ events in Mtz-treated fish remained at back-
ground levels after amputation and 4 days of regeneration (Fig-
ure S4B). These data indicate that no new osteoblasts were
contributed to the regenerate from resident osterix-expressing
cells that had escaped ablation.nc.
Figure 3. Osteoblast-Depleted Fins Regenerate Normally after Amputation
(A) Cartoon summarizing strategy to assess regeneration of amputated fins after genetic ablation of osteoblasts.
(B) Lengths of fin regenerates after osteoblast ablation and amputation. As a negative control, wild-type animals were treated with Mtz 2 days before amputation
and 4 days after amputation (wild-type, Mtz). osx:NTR animals treated with vehicle (osx:NTR, Veh) or Mtz (osx:NTR, Mtz) prior to amputation regenerated fins with
similar efficacy. Data are mean ± SEM from 15 animals each.
(C and D) osx:NTR; osc:EGFP animals had indistinguishable regenerative lengths at 4 dpa whether or not osteoblasts were present prior to amputation, and
indistinguishable osterix-driven expression in the regenerate. Osteoblast depletion proximal to the amputation plane is evident in Mtz-treated animals by the
absence of marker expression (D; bracket). Bottom images show osx:NTR fluorescence only. Arrowheads indicate the plane of amputation. Scale bar = 100 mm.
(E–P) Whole-mount views and longitudinal sections of fins at 2 (E–H), 3 (I–L), and 4 (M–P) dpa, highlighting osterix-driven NTR fluorescence. osx:NTR is unde-
tectable below the amputation plane of fins fromMtz-treated animals at 3 and 4 dpa, except for a trail of fluorescent cells at the amputation site. Tissue sections
indicate expression of osx:NTR in osteoblasts at each of the 3 time points, and ectopic osx:NTR fluorescence in intraray fibroblasts at 4 dpa in the Mtz treated
group (asterisk in P). Dotted lines and arrowheads indicate the plane of amputation. Scale bar = 100 mm.
See Figure S3.
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Bone Source Diversity in Regenerating FinsTo confirm that the b-actin2 promoter remained active in new
osteoblasts within these structures that had regenerated from
osteoblast-depleted fins, we gave these animals an additional
treatment with 4-HT for 12 hr at 2 dpa and analyzed fins at 3, 4,
and 7 dpa. Two days postamputation represents the earliest time
point at which we could detect recovered osx:NTR (and presum-Deveablyosx:CreERexpression) in the regenerate.Thisprotocol labeled
many cells in regenerating structures, and the proximodistal
domain of EGFP+ cells increasedwith the length of the regenerate.
EGFP was restricted to cells lining bone and was not detected
proximal to the amputation plane except for a small trail of cells
at the injury site (Figures 4E–4G and 4I). These findings indicatedlopmental Cell 22, 879–886, April 17, 2012 ª2012 Elsevier Inc. 883
Figure 4. New Osteoblasts Arise in the Regenerates of Osteoblast-Depleted Fins through De Novo Differentiation
(A) Cartoon depicting strategy that combines inducible lineage tracing and cell ablation in the osx:CreER; b-act2:RSG; osx:NTR background. 4-HT treatment
imparts a b-actin2-driven EGFP label in osteoblasts.
(B and C) 4-HT labels osteoblasts of uninjured fins with EGFP fluorescence (B). This label was undetectable after Mtz treatment (C), indicating efficient osteoblast
ablation.
(D) After amputation of fins of 4-HT-labeled and Mtz-treated animals, EGFP label was not detectable in 4 dpa regenerates or portions of the fins proximal to the
injury site. Because the label was driven by the b-actin2 promoter, this result indicates that EGFP loss in (C) was due to cell ablation and not downregulation of an
osteoblast marker.
(E–G) A second 4-HT treatment at 2 dpa generated EGFP+ cells in 3, 4, and 7 dpa regenerates, but not in portions of the fins proximal to the injury site. This result
indicates that, although b-actin2 expressing osteoblasts are not contributed by uninjured fin regions, the regenerated osteoblasts can still be labeled by EGFP via
their expression of osx:CreER and b-act2:RSG after amputation.
(H) Longitudinal section of uninjured fin corresponding to (C), indicating lack of EGFP fluorescence after 4-HT labeling and subsequent Mtz treatment.
(I) Longitudinal section of 3 dpa regenerate corresponding to (E), indicating that EGFP fluorescence induced by a postamputation 4-HT label is present in the
osteoblast compartment of the regenerated portion only. Scale bar = 100 mm.
See Figure S4.
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ablation andwere not a source of regenerated bone.We conclude
that in these experiments, regenerating bone has a lineage distinct
from osterix-expressing osteoblasts in the appendage stump.
DISCUSSION
Appendage regeneration has been studied for nearly 250 years,
but only recently have technologies become available to resolve884 Developmental Cell 22, 879–886, April 17, 2012 ª2012 Elsevier Ithe cellular basis of these events. Here,we applied a combination
of genetic cell ablation and fate-mapping approaches to define
the importance of existing osteoblasts in regeneration of the
skeletal bone of zebrafish fins. Our study adds key context to
the results of recent lineage-tracing experiments in regenerating
zebrafish fins, which highlighted a primary cellular mechanism
for bone regeneration in which existing osteoblasts undergo
dedifferentiation, proliferate, and contribute new osteoblasts
(Knopf et al., 2011; Sousa et al., 2011; Tu and Johnson, 2011).nc.
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Bone Source Diversity in Regenerating FinsAlthough we also observed this mechanism, our data indicate
that such events are dispensable, and that osteoblasts can
regenerate readily after amputation through de novo differentia-
tion. Thus, there aremultiple cellular sources with the potential to
contribute substantially to bone regeneration.
The combination of technologies we employed builds upon
strategies that have been reported over the past century and
have suggested the occurrence of transdifferentiation during
skeletal regeneration. In salamanders, new bone can develop
in the regenerate after removal of the skeletal elements and
subsequent amputation through the affected area (Thornton,
1938). Additionally, although irradiated limbs fail to regenerate
after amputation, transplantation of nonskeletal tissues can
rescue this capacity (Dunis and Namenwirth, 1977; Namenwirth,
1974). Similar experiments have been performed in teleost fins in
which entire fin rayswere extirpated before amputation, amanip-
ulation that has multiple interpretations and has yielded mixed
results (Goss and Stagg, 1957; Nabrit, 1929, 1931; Turner,
1941). Our approach using genetic tools clearly indicates that
nonosteoblast cells can be a primary or exclusive source of
new, patterned appendage skeleton.
Which cells regenerate bone in the absence of contributions
by skeletal osteoblasts? Intraray fibroblasts are the predominant
cell type in fins along with epidermis and share with osteoblasts
the expression of markers like msxb, msxc, sox9a, and Col2a1
(Akimenko et al., 1995; Smith et al., 2006), genes known in
mammals to instruct and/or indicate osteoblast fate decisions
(Karsenty, 2008). Thus, they represent primary candidates.
Indeed, the ectopic induction of osterix-driven fluorescence
that we observed in medially located fibroblasts after osteoblast
ablation and amputation may be a signature of their transdiffer-
entiation. If the fibroblasts are a bone source in zebrafish, their
contributions are analogous to the dermal contributions to carti-
lage indicated in a recent study of axolotl limb regeneration
(Kragl et al., 2009) and suggest an evolutionarily shared regener-
ative strategy. The use of inducible, Cre-based lineage-tracing
experiments is recent to the zebrafish model system, and to
our knowledge there is no marker or regulatory sequence with
demonstrated specificity to zebrafish fin fibroblasts. Thus, the
establishment of new reagents for specifically fate-mapping
fibroblasts, as well as other important fin cell types, will advance
the findings we report here.
Recent clonal analyses suggested that osteoblasts are not
clonal partners with intraray fibroblasts or other recognized fin
cell types during ontogeny or regeneration (Tu and Johnson,
2011). It is possible that a modified clonal analysis approach,
employing stable transgenic lines and irreversible labeling (e.g.,
Cre recombinase technology), would provide new opportunity
to represent all fin cells and recognize heterogeneous clone part-
ners (Tanaka and Reddien, 2011). On the other hand, it is
possible that osteoblast depletion triggers a novel source that
does not normally participate in regeneration of amputated fin
rays. There are precedents for dormant regenerative mecha-
nisms that emerge predominantly in special contexts. For
instance, pancreatic b-cells regenerate after resection injury by
self-replication (Dor et al., 2004), yet can be replenished by
duct cell or a-cell transdifferentiation after injuries of ischemia
or extreme b-cell loss, respectively (Thorel et al., 2010; Xu
et al., 2008). Thus, it will be important to determine the extentDeveto which nonosteoblasts contribute bone in the presence of
a full complement of osteoblasts, and to identify signals that
recognize source availability and regulate output from diverse
sources. Determining the breadth and plasticity of cellular
sources in spectacular examples of bone reconstitution like
zebrafish fin regeneration stands to illuminate potential therapies
of major bone injury or loss in humans.
EXPERIMENTAL PROCEDURES
Zebrafish
Wild-type or transgenic zebrafish of the outbred Ekkwill (EK) or a hybrid EK/AB
strain of 4–6 months of age were used for all experiments. Caudal fin amputa-
tions were performed with a razor blade on fish anesthetized with tricaine, and
removed one-half of fins. The transgenic b-act2:RSG line has been described
previously (Kikuchi et al., 2010). osx:mCherry and osc:EGFP constructs were
generated by subcloning mCherry and EGFP cassettes downstream of pub-
lished promoter sequences of medaka osterix and osteocalcin genes (Inohaya
et al., 2007; Renn and Winkler, 2009). For osx:NTR, we subcloned mCherry,
fused to a human codon-optimized version of the Escherichia coli enzyme
Nitroreductase, downstream of the osterix regulatory fragment (Grohmann
et al., 2009). To generate osx:CreER, a bicistronic construct containing the
coding sequence for mTagBFP (Evrogen) (Subach et al., 2008) and sequences
encoding a tamoxifen-inducible Cre recombinase-estrogen receptor fusion
protein, separated by a 2A viral linker sequence (Provost et al., 2007; Trichas
et al., 2008), were subcloned downstream of the osterix promoter. mTagBFP
aided visualization of CreER expression in embryos, useful for identifying
and maintaining the transgenic line. Plasmid constructs were coinjected with
I-SceI into one-cell zebrafish embryos for linearization, and all transgenic
strains were analyzed as hemizygotes.
For 4-HT labeling, adult zebrafish were incubated with aquarium water
containing 5 mM 4-HT, made from a 1 mM stock solution in 100% ethanol.
Fish were maintained in 4-HT in the dark for the indicated periods of time,
and then were rinsed and returned to recirculating aquarium water. Experi-
ments with zebrafish were approved by the Institutional Animal Care and
Use Committee at Duke University. For osteoblast ablation, fish were incu-
bated with 10 mM Mtz (Sigma, M1547) dissolved in aquarium water, and
maintained for 24 hr in the dark before they were rinsed and returned to
recirculating aquarium water.
Fin Length Measurement and Analysis
Leica Application Suite software was used to measure fin regenerates from
images of live, anaesthetized fish. The distances from the amputation plane
to the distal tips of the second and third lateral-most rays on the dorsal lobe
was measured. These lengths were averaged to give one value per animal.
Unpaired Student’s t tests were performed to determine p values.
Histological Methods
TUNEL staining on whole-mount fins was performed using a previously
described protocol (Wills et al., 2008). For BrdU-labeling experiments, animals
were injected intraperitoneally with 0.05 ml of a 2.5 mg/ml solution of BrdU
dissolved in water. BrdU was injected 5 hr before fin collection, and immuno-
detection of BrdUwas performed as described (Lee et al., 2005). In situ hybrid-
ization on cryosections was performed using digoxygenin-labeled runx2a
(Li et al., 2009) or osterix RNA probes as described previously (Poss et al.,
2002). The monoclonal Zns5 (1:50 dilution; Zebrafish International Resource
Center), polyclonal DsRed (1:500 dilution; Clontech) and polyclonal p63
(1:200 dilution; Abcam) antibodies were used for immunofluorescence
analysis.
Flow Cytometry
Adult zebrafish caudal fins were amputated and dissociated by vigorous
shaking for 20 min at room temperature in a solution of Liberase DH Research
Grade (Roche) reconstituted in Hank’s buffered salt solution (HBSS) buffer.
The cells were briefly spun down and resuspended in HBSS, and then passed
through a 40 mm filter. Propidium iodide (Sigma) was added to a concentration
of 1 mg/ml. Flow cytometry analysis was performed using a BD FACSCanto IIlopmental Cell 22, 879–886, April 17, 2012 ª2012 Elsevier Inc. 885
Developmental Cell
Bone Source Diversity in Regenerating Fins(BD Biosciences), using forward and side scatter parameters to exclude cell
debris.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.devcel.2012.03.006.
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